Understanding HAIs: Ally proteins in the fight against cancer

Research output: Contribution to journalComment/debateResearchpeer-review

Documents

  • Fulltext

    Final published version, 228 KB, PDF document

Understanding how HAI-1 and HAI-2 regulate the epithelial serine protease matriptase may hold the key to curing epithelial-derived cancer. HAIs are serine protease inhibitors that inhibit matriptase and have a poorly understood effect on the presence of matriptase protein in cells. In this issue of The FEBS Journal, Yamashita et al. provide much-needed new insights into this effect, describing it as a ‘chaperone-like function’ of HAI-1. However, several observations suggest that matriptase folds correctly without HAIs and that HAIs are not chaperones. We introduce the concept of ‘ally proteins’ to categorize the poorly understood function of HAIs, distinguishing them from chaperones. Comment on: https://doi.org/10.1111/febs.16348.

Original languageEnglish
JournalFEBS Journal
Volume289
Issue number12
Pages (from-to)3416-3418
ISSN1742-464X
DOIs
Publication statusPublished - 2022

Bibliographical note

Publisher Copyright:
© 2022 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies

    Research areas

  • ally protein, cancer, chaperone, HAI-1, HAI-2, malignant tumour, matriptase

ID: 299491760